8: No. 2, March 2011
Barriers to Colorectal Cancer Screening: Physician and General Population Perspectives,
New Mexico, 2006
Richard M. Hoffman, MD, MPH; Robert L. Rhyne, MD, MPH; Deborah L. Helitzer, ScD; S. Noell Stone, MPH; Andrew L. Sussman, PhD, MCRP; Elizabeth E. Bruggeman, PhD, MA; Robyn Viera; Teddy D. Warner, PhD
Suggested citation for this article: Hoffman RM, Rhyne RL, Helitzer DL, Stone SN, Sussman AL, Bruggeman
EE, et al. Barriers to colorectal cancer screening: physician and general
population perspectives, New Mexico, 2006. Prev Chronic Dis 2011;8(2):A35.
http://www.cdc.gov/pcd/issues/2011/mar/10_0081.htm. Accessed [date].
Colorectal cancer (CRC) screening rates are low in New Mexico. We used statewide surveys of primary care physicians and
the general population to characterize CRC screening practices and compare perceptions about screening barriers.
In 2006, we surveyed 714 primary care physicians in New Mexico about their CRC screening practices, beliefs, and perceptions of patient, provider, and system barriers. A 2004 state-specific CRC screening module for the Behavioral Risk Factor Surveillance System (BRFSS) survey asked 3,355 participants aged 50 years or older why they had not ever or
had not recently completed a fecal occult blood test (FOBT) or lower endoscopy.
The 216 physicians (30% response rate) reported offering screening to a median 80% of their average-risk patients in the past year and estimated that a median 50% were current with screening. They attributed low screening proportions mainly to patient factors (embarrassment, fear of pain, lack of insurance). However, just 51% of physician respondents used health maintenance flow sheets, and only 13% used electronic medical records to identify patients due for CRC screening. The BRFSS
respondents most often reported that lack of physician discussion was responsible for not being current with screening (45% FOBT, 34% endoscopy); being asymptomatic was also often cited as an explanation for lack of screening (22% FOBT, 36% endoscopy).
Physicians and adults in the general population had markedly different perspectives on barriers to CRC screening. Increasing screening may require system supports to help physicians readily identify patients due for CRC testing and interventions to educate patients about the rationale for screening.
Back to top
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer in New Mexico and the second leading cause of cancer death (1). In 2009, an estimated 800 new CRC cases were diagnosed in New Mexico, and
approximately 300 people died from this disease. Although CRC screening reduces both CRC incidence and mortality (2-4), just over half of New Mexican adults aged 50 years or older are considered current with screening (5). Consequently, fewer than half of the cancers in New Mexico are being
diagnosed at an early stage, when they can be most effectively treated (6).
In New Mexico, the Clinical Prevention Initiative, a statewide partnership of health care organizations supported by the New Mexico Department of Health and the Centers for Disease Control and Prevention (CDC) (7), works to increase the delivery of high-impact preventive services (8) by targeting primary care providers. To guide interventions, the Clinical Prevention Initiative CRC workgroup decided to survey primary care providers to assess perceived barriers to CRC screening. The
Department of Health had also recently collected population-based data on screening barriers through CDC’s Behavioral Risk Factor Surveillance System (BRFSS) survey.
Although numerous barriers and facilitators to CRC screening have been identified in the literature (9-14), including patient, provider, health system, and policy factors, few surveys have been able to compare contemporaneous responses from providers and a general population (15). Furthermore, many studies were conducted before Medicare began reimbursing for screening colonoscopy in 2001 and before the 2002
publication of US Preventive Services Task Force (USPSTF) guidelines strongly recommending CRC
screening (16), which substantially altered screening practices (5,17). Results from other states or regions may not necessarily be applicable in New Mexico; a lower proportion of New Mexicans is screened for CRC compared with national averages (54.8% vs 57.3%) (5). Additionally, national data show declining CRC incidence from 1997
through 2006 for both sexes and all major racial/ethnic groups (18); however, incidence in New Mexico has been stable or increasing among Hispanics and American
Indians (6). New Mexico is the fifth largest state but only the 36th most populated state and has substantially higher than national population percentages of Hispanics (45% vs 15%) and American Indians (10% vs 1%) (19). Given New Mexico’s anomalous trends in CRC incidence and diverse minority populations, the primary objective of our study was to comprehensively characterize provider-reported practices and barriers for CRC screening. A secondary objective was to compare these provider
perceptions with those of the general population.
Back to top
A team of content and methodology experts at the University of New Mexico Cancer Center developed the primary care physician survey in 2005. Some items were adapted from a National Cancer Institute survey on CRC screening barriers (15). We revised the survey after pilot testing it with a sample of 5 primary care physicians who assessed content and face validity. The final 34-item survey was divided into 6 sections that addressed the practice strategies and system support for performing
screening (patient education, reminders, tracking), the rationale for recommending screening (influential factors), cancer screening beliefs and practices (perceived effectiveness, testing recommendations, patient adherence), screening barriers (patient, provider, system), practice characteristics (type, location, size), and physician characteristics (demographics, specialty).
(Readers can obtain a copy of the survey from the corresponding author.) Screening practice items were based on USPSTF
recommendations (16) for average-risk patients aged 50 years or older and included the options of colonoscopy, flexible sigmoidoscopy, barium enema, or fecal occult blood testing (FOBT). We used 6-point rating scales ranging from “never”/“not” = 1 to “most”/“very” = 6 to measure survey items assessing screening beliefs, practices, and barriers. The human research review committee of the University of New Mexico approved the physician survey.
We identified potential respondents from the 2006 New Mexico Board of Medical Examiners provider list, which contains the self-identified specialties and addresses for licensed physicians in New Mexico. The eligibility criterion was a primary specialty listing of internal medicine, family medicine, general practice, or geriatrics. We excluded physicians with secondary specialties that indicated that they were not primary care providers, including medical subspecialties, urgent care,
We mailed 964 surveys in June 2006 accompanied by a cover letter signed by leaders of primary care professional organizations and the New Mexico Department of Health. We subsequently mailed surveys approximately 3 and 5 months later to nonrespondents. We did not offer compensation for participating in the survey.
On the basis of returned mailings, updated Medical Examiners lists, and survey responses, we excluded 123 physicians from our denominator because we could not locate them and another 127
physicians who either were no longer licensed in New Mexico (retired or moved) or who were not primary care providers. We were left with a denominator of 714 respondents and 216 completed surveys, for a response rate of 30%.
The study participants were a population-based sample of respondents to the 2004 New Mexico BRFSS, a federally funded annual survey implemented in collaboration with state health departments. Random-digit dialing methods were used to derive a probability sample of households with telephones to collect data on health-related behaviors and risk factors for respondents aged 18 years or older. In 2004, the New Mexico Department of Health designed a module that was administered to 6,390 adults
aged 50 years or older that asked about CRC screening with a home FOBT and lower endoscopy. Overall, 3,355 participants who reported being
not current or never tested with either home FOBT or lower endoscopy were asked to provide the most important reason for the lack of testing. These participants included 1,695 who had never performed a home
FOBT and 798 who had not been tested in the past year, as well as 1,504 who never had undergone a sigmoidoscopy or colonoscopy
and 297 who had not been tested in the past 5 years.
For the physician survey, we used descriptive statistics to characterize providers, practices, screening practices, and ratings of barriers to screening. We conducted a series of exploratory factor analyses on the patient, provider, and system barriers assessed by the survey to confirm that survey items clustered within these 3 distinct groups of barriers. We used factorial within-subjects multivariate analyses of variance to directly compare physician rating levels within each set of
barriers to CRC screening (20).
To account for the complex survey design of the BRFSS, we used Stata 9.0 (StataCorp LP, College Station, Texas) to estimate percentages and their
95% confidence intervals (CIs) by demographic characteristics. All estimates represent weighted population-based estimates for residents aged 50
years or older who responded to the 2004 New Mexico BRFSS.
Back to top
Among the physician respondents who completed these survey items, most were middle-aged white men who practiced in urban areas
(Table 1). Almost half practiced in physician-owned, single-specialty practices, and
most worked in small groups.
Few practices used an electronic medical record to identify patients due for CRC screening and most did not have a mechanism to ensure that patients
completed FOBT tests
(Table 2). However, few respondents found it difficult to arrange CRC screening.
The most influential factors for screening, on a 6-point scale from 1 (not at all influential) to 6 (very influential), were evidence from the medical literature and professional guidelines. Respondents considered screening colonoscopy to be the most effective strategy for reducing CRC mortality. They were less enthusiastic about FOBT, flexible sigmoidoscopy, and barium enema.
Colonoscopy was recommended at least some of the time for screening average-risk patients by 94% of respondents compared with 86% for FOBT. Overall, 74% of respondents never recommended flexible sigmoidoscopy, and 74% never recommended barium enema. Nearly all respondents reported that they began screening average-risk patients at age 50 for each of the screening procedures except FOBT, for which 23% reported that they began screening patients in their 40s. The mean (standard deviation)
screening interval in years was 1.4 (1.6) for FOBT, 8.2 (2.6) for colonoscopy, 6.3 (2.4) for barium enema, and 4.5 (1.3) for flexible sigmoidoscopy. Nearly all respondents indicated that they had an upper age limit for screening with colonoscopy, barium enema, and flexible sigmoidoscopy; about half indicated that they would not screen beyond age 80. However, 63% of respondents reported not having an upper age limit for FOBT screening.
In the past year, respondents estimated offering CRC screening to a median (interquartile range) 80% (70%-95%) of their patients aged 50
years or older. Overall, respondents estimated that 50% (40%-70%) of their eligible patients were current with CRC screening recommendations.
Only 3 patient barriers were rated 4 or higher on the 6-point rating scale: embarrassment/anxiety, fear of pain, and inadequate insurance (Table 3). Physician barriers were all rated below the midpoint of 3.5 on the 6-point rating scale, indicating that physicians did not see themselves as often creating barriers to screening. Similarly, physicians generally did not perceive system factors, which were categorized into implementing screening and obtaining lower endoscopy, as creating barriers
Among the 3,355 respondents to the BRFSS module questions about lack of screening, 58% were aged 50 to 64
years, 47% were men, 67% were non-Hispanic whites, and 26% were Hispanic. By far, the most frequently cited response for never having undergone
CRC screening or not being current with either FOBT or lower endoscopy was that
a doctor never suggested testing
(Table 4). A substantial proportion of participants indicated that lack of symptoms was the reason for not being screened.
Few reported testing being distasteful or embarrassing, having fear of cancer, or having fear of pain with testing as barriers. Furthermore, access and cost issues were not frequently listed as barriers for FOBT, though they were slightly more common for endoscopic procedures.
Back to top
We found that physicians and patients had markedly different perspectives on barriers to CRC screening. Although physicians reported offering screening to most of their average-risk patients, they acknowledged limited adherence. Physicians most often cited patient factors as being frequent barriers, including fear of pain, embarrassment and anxiety about testing, lack of insurance, and lack of knowledge about cancer and screening. Meanwhile, population-based data from
adults aged 50 years or older showed that they rarely considered discomfort or embarrassment to be a primary barrier. Respondents were far more likely to report that lack of a physician recommendation or lack of symptoms prevented them from getting tested.
Other investigators have also noted a discrepancy between physician and patient perspectives on barriers, though not at a statewide level. Klabunde and colleagues compared results from nearly concurrent national surveys of providers (1999-2000 Survey of Colorectal Cancer Screening Practices) and adults in the general population (2000 National Health Interview Survey [NHIS]) (15). Investigators asked a nationally representative sample of primary care providers to rate the importance of
patient and health care system barriers to screening with either FOBT or lower endoscopy. More than 90% of the physician respondents identified at least 1 major barrier, more often patient-related (80%) than system-related (68%). The most frequently cited patient barriers were embarrassment/anxiety about testing (56%), lack of awareness of screening/not perceiving the seriousness of CRC (48%), and fear of finding cancer (28%). The most frequently cited system barrier was financial (46%). In
contrast, only 1% of NHIS respondents reported concerns about pain or embarrassment as major barriers for lower endoscopy. The most frequently cited barriers by patients were not seeing a need for testing/lack of awareness (51%), which was concordant with the physicians’ responses; however, 21% also reported that their doctor did not order or recommend the test.
Physicians’ failure to discuss screening is a common theme in patient surveys. Even though lack of time to discuss screening was not seen as a frequent barrier by our respondents, the literature suggests otherwise. Yarnall and colleagues estimated that it would take 7.4 hours a day for a provider in an adult primary care practice to address the preventive services deemed effective by USPSTF (21). Competing health demands can make it difficult to address screening during routine office
visits, and a meta-analysis found that conducting a prevention visit was significantly associated with being able to deliver more screening (22).
Additionally, only one-third of our respondents reported that their practice had written policies for CRC screening, and availability of tracking systems and electronic medical records was limited. This may be an unrecognized provider barrier to discussing screening. Inadequate use of office systems has been identified as a major barrier for achieving screening (23,24). Developing office policies is seen as a necessary first step to ensuring system changes (25), and employing a tracking
system can facilitate effective screening by identifying patients who are due for screening (or surveillance) — and ensuring that results of screening and diagnostic tests are documented (24).
Physician-patient communication about CRC screening may be less than ideal. Our results suggest that physicians may not be fully aware of patients’ attitudes and values toward screening. Ling and colleagues studied attitudes toward CRC screening among physicians and patients at a single academic practice (26). Physicians markedly overestimated test discomfort as a barrier compared with patients and underestimated the importance of test accuracy for patients. Physicians may also not
recognize the importance of helping patients make informed decisions for screening. CRC screening is a complex issue because multiple testing options are available, and
various criteria are used to assess risks (27,28). These concepts can be difficult to convey, and the literature suggests that discussions often do not take place (29) or are inadequate (30,31). One study analyzed audiotaped clinic visits and found that although 40% of discussions provided patients with background
information about screening, most did not address alternatives (74%) or pros and cons (83%), or elicit patient preferences (83%). Conversely, providing patients with a CRC screening decision aid that informed them about cancer risks and available effective tests was associated with a significant increase in completing screening tests (32).
The physician survey responses also revealed some implicit barriers to effective screening. Physicians believed that colonoscopy was more effective than FOBT and flexible sigmoidoscopy. This finding mirrors national survey results (33) and may be attributed to guidelines that rate colonoscopy as the optimal test (34). However, the objective evidence for screening effectiveness for FOBT is based on randomized controlled trials (2),
whereas only case-control and observational data support the
effectiveness of colonoscopy (35-37). Consequently, USPSTF gives an overall “A” rating to CRC screening, without recommending any specific tests (27). In New Mexico, capacity for colonoscopy is limited (38), suggesting that using alternative tests may be necessary to achieve higher screening rates.
issue was the potential for overscreening elderly patients. Among respondents
to the questions about stopping screening, 63% did not indicate any upper age
for stopping FOBT, while 55% of those who set an upper age for colonoscopy would
continue recommending screening past age 80. USPSTF recommends that screening not be offered for patients aged 85
years or older and offered only after a risk-benefit discussion with patients aged 76 to 84
years because patients with limited life expectancy have little expected benefit from
screening (27). Other provider surveys have also indicated insufficient consideration of patient age when making screening recommendations (39,40). Although
the FOBT is inexpensive and safe, false-positive results are common and abnormal studies require diagnostic colonoscopy. Screening patients who are unlikely to receive any benefit is an inefficient use of resources.
Our study had some potential limitations. The overall response rate to the physician survey was low, creating a potential selection bias if respondents were not representative of the population of New Mexico primary care physicians. However, a recent
New Mexico Health Policy Commission
(NMHPC) report suggests that the demographics of our sample were consistent with statewide data on primary care physicians (41). In 2008, the NMHPC reported that 43% of primary care physicians were aged 55 or
older (vs 39% in our sample), 56.9% were men (vs 68%), and 48% were in the county containing Albuquerque (vs 47%). We also know that our denominator of potentially eligible physicians was not accurate and that we likely underestimated our response rate. We relied on the Board of Medical Examiners physician listings, which do not consistently characterize specialty or training status, so we may have misclassified specialists and trainees as being primary care physicians. Contact information is
updated only every 3 years, so we could not be certain that we had correct addresses. However, our results in terms of practice patterns, system support, and barriers are consistent with those of other surveys reporting higher response rates (15,33). We were also unable to verify provider responses regarding screening practices and adherence.
The BRFSS data are subject to selection and recall bias, although reports of physicians failing to recommend screening are supported by national surveys (15) as well as directly observed patient encounters (31). Social desirability bias may have caused respondents to minimize fear and embarrassment as screening barriers. Finally, our data are ecologic; physician and BRFSS respondents are not directly linked, which could result in differing perceptions of barriers, particularly related to
Our results suggest that CRC screening in New Mexico could be facilitated by information systems that readily identify patients who are due for screening and track test results. Physicians may also increase screening by educating patients about cancer and the rationale and options for screening. Physicians in a state with limited resources for cancer screening should also avoid potentially inefficient (not having an upper age limit for FOBT screening) and impractical (emphasizing screening
colonoscopy) screening strategies.
Back to top
work was funded by New Mexico Department of Health Public
Health Division/Comprehensive Cancer Program grant no. 05/665.0100.0179. This work was supported by the New Mexico VA Health Care System, Albuquerque, New Mexico, and the New Mexico Clinical Prevention Initiative.
Back to top
Corresponding Author: Richard M. Hoffman, MD, MPH, New Mexico VA Health Care System, 1501 San Pedro Dr SE, Mailstop 111, Albuquerque, NM 87108. Telephone: 505-265-1711, ext 5318. E-mail:
email@example.com. Dr Hoffman is also affiliated with the Department of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.
Author Affiliations: Robert L. Rhyne, Deborah L. Helitzer, S. Noell Stone, Andrew L. Sussman, Robyn Viera, Teddy D. Warner, University of New Mexico School of Medicine, Albuquerque, New Mexico; Elizabeth E. Bruggeman, New Mexico Department of Health, Cancer Prevention and Control Section, Chronic Disease Prevention and Control Bureau, Albuquerque, New Mexico.
Back to top
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.
Cancer statistics, 2009. CA Cancer J Clin 2009;59(4):225-49.
- Hewitson P, Glasziou P, Watson E, Towler B, Irwig L.
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103(6):1541-9.
- Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al.
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343(22):1603-7.
- Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al.
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375(9726):1624-33.
- Use of colorectal cancer tests — United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 2008;57(10):253-8.
- Hoffman RM, Stone SN, Viera RL. Colorectal cancer in New Mexico. A handbook for health care professionals. New Mexico Department of Health; 2008. http://www.health.state.nm.us/ERD/HealthData/Cancer/FINAL_cpi-04handbook_colorectal.pdf. Accessed June 1, 2010.
- Espey DK, Baum SL, Jung AM, Kozoll RL.
The New Mexico Clinical Prevention Initiative: a statewide prevention partnership. Public Health Rep 2007;122(3):292-301.
- Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, et al.
Priorities among recommended clinical preventive services. Am J Prev Med 2001;21(1):1-9.
- Provenzale D, Gray RN.
Colorectal cancer screening and treatment: review of outcomes research. J Natl Cancer Inst Monogr 2004;(33):45-55.
- Vernon SW.
Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89(19):1406-22.
- Subramanian S, Klosterman M, Amonkar MM, Hunt TL.
Adherence with colorectal cancer screening guidelines: a review. Prev Med 2004;38(5):536-50.
- Sabatino SA, Habarta N, Baron RC, Coates RJ, Rimer BK, Kerner J, et al.
Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers: systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med 2008;35(1 Suppl):S67-74.
- Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, et al.
Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening: a systematic review. Am J Prev Med 2008;35(1 Suppl):S34-55.
- Baron RC, Rimer BK, Coates RJ, Kerner J, Kalra GP, Melillo S, et al.
Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening: a systematic review. Am J Prev Med 2008;35(1 Suppl):S56-66.
- Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML.
Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 2005;43(9):939-44.
- US Preventive Services Task Force.
Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137(2):129-31.
- Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML.
Trends in colorectal cancer test use in the
Medicare population, 1998-2005. Am J Prev Med 2009;37(1):1-7.
- Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al.
Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116(3):544-73.
- US Census Bureau. State and county QuickFacts. http://quickfacts.census.gov/qfd/index.html. Accessed June 1, 2010.
- Tabachnik B, Fidell L. Using multivariate statistics. 5th edition. Upper Saddle River (NJ): Allyn and Bacon; 2007.
- Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL.
Primary care: is there enough time for prevention? Am J Public Health 2003;93(4):635-41.
- Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, et al.
Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002;136(9):641-51.
- Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R.
Healthcare system factors and colorectal cancer screening. Am J Prev Med 2002;23(1):28-35.
- Sarfaty M, Wender R.
How to increase colorectal cancer screening rates in practice. CA Cancer J Clin 2007;57(6):354-66.
- Wei EK, Ryan CT, Dietrich AJ, Colditz GA.
Improving colorectal cancer screening by targeting office systems in primary care practices: disseminating research results into clinical practice. Arch Intern Med 2005;165(6):661-6.
- Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC.
Attitudes toward colorectal cancer screening tests. J Gen Intern Med 2001;16(12):822-30.
- Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149(9):627-37.
- Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al.
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134(5):1570-95.
- Dunn AS, Shridharani KV, Lou W, Bernstein J, Horowitz CR.
Physician-patient discussions of controversial cancer screening tests. Am J Prev Med 2001;20(2):130-4.
- Lafata JE, Divine G, Moon C, Williams LK.
Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med 2006;31(3):202-9.
- Ling BS, Trauth JM, Fine MJ, Mor MK, Resnick A, Braddock CH, et al.
Informed decision-making and colorectal cancer screening: is it occurring in primary care? Med Care 2008;46(9 Suppl 1):S23-9.
- Pignone M, Harris R, Kinsinger L.
Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med 2000;133(10):761-9.
- Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW.
Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med 2009;37(1):8-16.
- Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM.
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].
[published correction appears in Am J Gastroenterol 2009;104(6):1613]. Am J Gastroenterol 2009;104(3):739-50.
- Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L.
Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150(1):1-8.
- Muller AD, Sonnenberg A.
Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155(16):1741-8.
- Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, et al.
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329(27):1977-81.
- Hoffman RM, Stone SN, Herman C, Jung AM, Cotner J, Espey D, et al. New Mexico’s capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies. Prev Chronic Dis 2005;2(1).
http://www.cdc.gov/pcd/issues/2005/jan/04_0073.htm. Accessed October 15, 2010.
- Kahi CJ, van Ryn M, Juliar B, Stuart JS, Imperiale TF.
recommendations for colorectal cancer screening in elderly veterans. J
Gen Intern Med 2009;24(12):1263-8.
- Walter LC, Lindquist K, Nugent S, Schult T, Lee SJ, Casadei MA, et al.
Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med 2009;150(7):465-73.
- 2008 Geographic Access Data System. Selected healthcare professionals in New Mexico. New Mexico Health Policy Commission; 2009. http://www.hpc.state.nm.us/documents/GADS_2008.pdf. Accessed June 1, 2010.
Back to top